Imaging and liquid biopsy in the prediction and evaluation of response to PRRT in neuroendocrine tumors: implications for patient management.
Wolfgang RollMatthias WeckesserRobert SeifertLisa BodeiKambiz RahbarPublished in: European journal of nuclear medicine and molecular imaging (2021)
New response criteria for NET patients undergoing PRRT will comprise multiparametric hybrid imaging and blood-based multianalyte markers. This represents tumor biology and heterogeneity.